tradingkey.logo

Vsee Health Inc

VSEE
1.010USD
-0.010-0.98%
Cierre 11/05, 16:00ETCotizaciones retrasadas 15 min
16.59MCap. mercado
PérdidaP/E TTM

Vsee Health Inc

1.010
-0.010-0.98%

Más Datos de Vsee Health Inc Compañía

VSee Health, Inc. operates through its subsidiaries, VSee Lab, Inc. (VSee) and iDoc Virtual Telehealth Solutions, Inc. (iDoc). VSee is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. VSee’s system allows a telehealth mobile app to be created or a telehealth system to be integrated into existing hospital operations in days. VSee provides patient engagement solutions, clinician staffing solutions, remote physical exam and remote patient monitoring solutions, and AI for telesitter and telenursing solutions. iDoc is an acute care organization that treats and coordinates care for acutely ill patients 24/7 in the neurointensive care unit (Neuro-ICU), cardiac surgery intensive care unit (CSICU) and the intensive care unit (ICU) for stroke, brain trauma and a broad range of neurological conditions. iDoc is a provider of teleneurointensivists for neuro-critical care.

Información de Vsee Health Inc

Símbolo de cotizaciónVSEE
Nombre de la empresaVsee Health Inc
Fecha de salida a bolsaNov 04, 2021
Director ejecutivoDr. Milton Chen, Ph.D.
Número de empleados154
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 04
Dirección980 N Federal Hwy
CiudadBOCA RATON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33432
Teléfono15616727068
Sitio Webhttps://vsee.com/
Símbolo de cotizaciónVSEE
Fecha de salida a bolsaNov 04, 2021
Director ejecutivoDr. Milton Chen, Ph.D.

Ejecutivos de Vsee Health Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Imoigele Aisiku, M.D.
Dr. Imoigele Aisiku, M.D.
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
3.26M
-4.69%
Dr. Milton Chen, Ph.D.
Dr. Milton Chen, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.84M
-1.00%
Dr. Scott Metzger
Dr. Scott Metzger
Independent Director
Independent Director
8.63K
--
Mr. Kevin Lowdermilk
Mr. Kevin Lowdermilk
Independent Director
Independent Director
--
--
Mr. David L. Wickersham
Mr. David L. Wickersham
Independent Director
Independent Director
--
--
Mr. Jerry Leonard
Mr. Jerry Leonard
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Colin O'Sullivan
Mr. Colin O'Sullivan
Independent Director
Independent Director
--
--
Ms. Cydonii V. Fairfax
Ms. Cydonii V. Fairfax
Independent Director
Independent Director
--
--
Mr. Dave Gentry
Mr. Dave Gentry
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Imoigele Aisiku, M.D.
Dr. Imoigele Aisiku, M.D.
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
3.26M
-4.69%
Dr. Milton Chen, Ph.D.
Dr. Milton Chen, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.84M
-1.00%
Dr. Scott Metzger
Dr. Scott Metzger
Independent Director
Independent Director
8.63K
--
Mr. Kevin Lowdermilk
Mr. Kevin Lowdermilk
Independent Director
Independent Director
--
--
Mr. David L. Wickersham
Mr. David L. Wickersham
Independent Director
Independent Director
--
--
Mr. Jerry Leonard
Mr. Jerry Leonard
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: vie., 24 de oct
Actualizado: vie., 24 de oct
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Aisiku (Imoigele)
19.13%
Chen (Milton)
16.69%
Digital Health Sponsor LLC
16.63%
Homrich Berg
3.54%
SCS Capital Management LLC
2.94%
Otro
41.07%
Accionistas
Accionistas
Proporción
Aisiku (Imoigele)
19.13%
Chen (Milton)
16.69%
Digital Health Sponsor LLC
16.63%
Homrich Berg
3.54%
SCS Capital Management LLC
2.94%
Otro
41.07%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
37.13%
Corporation
16.63%
Investment Advisor/Hedge Fund
7.05%
Investment Advisor
0.74%
Venture Capital
0.07%
Hedge Fund
0.02%
Research Firm
0.01%
Otro
38.35%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
25
1.34M
7.89%
+110.08K
2025Q2
31
9.92M
63.30%
-1.88M
2025Q1
31
10.50M
67.03%
-685.58K
2024Q4
28
9.85M
62.87%
-1.21M
2024Q3
61
10.11M
73.63%
-10.21M
2024Q2
59
10.44M
76.15%
-2.85M
2024Q1
65
3.46M
96.42%
-12.49M
2023Q4
66
3.44M
82.48%
-12.61M
2023Q3
66
4.08M
97.64%
-11.96M
2023Q2
66
4.08M
97.52%
-11.93M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Aisiku (Imoigele)
3.26M
19.83%
-160.37K
-4.69%
Aug 15, 2025
Chen (Milton)
2.84M
17.3%
-28.70K
-1.00%
Aug 15, 2025
Digital Health Sponsor LLC
2.83M
17.24%
+201.13K
+7.65%
Aug 15, 2025
SCS Capital Management LLC
500.00K
3.04%
--
--
Jun 24, 2024
Wickersham (David L.)
214.00K
1.3%
+100.00K
+87.72%
Aug 15, 2025
Geode Capital Management, L.L.C.
78.10K
0.48%
+1.65K
+2.16%
Jun 30, 2025
UBS Financial Services, Inc.
52.51K
0.32%
-37.64K
-41.75%
Jun 30, 2025
Osaic Holdings, Inc.
45.17K
0.28%
+29.98K
+197.46%
Jun 30, 2025
State Street Investment Management (US)
18.90K
0.12%
--
--
Jun 30, 2025
Ver más

ETFs relacionados

Nombre
Proporción
Sin datos

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI